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Protein phosphorylation is one of the key protein post-translational modifications (PTMs), and it 
regulates biological process by dynamic phosphorylation and dephosphorylation. Especially, 
phosphorylation is involved in many signal transduction pathways, and some are related to human 
diseases. For this reason, kinase and phosphatases have been actively investigated as drug targets. Stable 
O-phosphorylations, such as phosphoserine (pSer), phosphothreonine (pThr), and phosphotyrosine 
(pTyr) are well-studied, and many tools are available. However, unstable phosphorylations, such as 
phospholysine(pLys), phosphohistidine (pHis) and phosphoaspartate (pAsp) are still much less explored 
due to their chemical instability and the lack of tools. In this thesis, my progress towards the development 
of chemical tools for studying pLys and pAsp.  
 
Chapter I describes our strategies and progress toward the development of phospholysine-specific 
antibodies, including the design and synthesis of the antigen, the affinity purification of the crude 
antisera, and the validation of the purified antibodies.  
 
In chapter II, the chemistry of pAsp and its biological functions are briefly reviewed. Then our 
efforts for covalent labeling of pAsp and subsequent detection are described. Our approach was validated 
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Chapter 1. Development of pLys-specific antibody 
 
1. Introduction 
1.1. Protein phosphorylations 
Protein phosphorylation is one of the key post-translational modifications (PTMs) in cells. It 
regulates lots of physiological processes in diverse biological systems. Especially, protein 
phosphorylation and dephosphorylation mediates signal transductions, catalyzed by kinase or 
phosphatase. Regulation of cellular signal transduction mechanism is also associated with diseases, so 
protein kinases have been drug targets in pharmaceutical field.1 
Among many phosphoamino acids, O-phosphoylations, such as pSer, pThr, pTyr are well known 
and studied, due to their stability in acids. It was possible to develop the tools for phosphoprotein or 
peptide analysis, such as antibody and IMAC. However, protein N-phosphorylations, such as 
phosphohistidine (pHis), phosphoarginine (pArg) and phospholysine (pLys) are unstable under acidic 
conditions, and this instability hindered the elucidation of biological roles of N-phosphorylations. 
Despite the difficulties of classical biological tools, due to the development of tools with chemical 
approaches enabled the researches on non-conventional phosphoamino acid. First pan-specific pHis 
antibody was developed by Kee et al., using synthetically prepared pHis analog.2 Similar with this 
approach, pArg antibody was also discovered. But still, pLys antibody is not reported yet.3,4 
 
1.2 Chemistry of pLys 
Among phosphoamino acids, pLys is especially labile in acidic conditions. The phosphoramidate 
of pLys was completely hydrolyzed within 15 min at room temperature in 1 M hydrochloric acid. At pH 
below 9, nitrogen atom of pLys is protonated, and it makes the amino group a better leaving group and 
lengthens the P-N bond. These facilitate the hydrolysis of pLys (Scheme 1). It is known that the rate 
constant of pLys monoanion (pH 7) hydrolysis is 16.4 min-1 while the rate constant of neutral N-
butylphosphoramidate (acidic pH) is 142 min-1.5,6 However. pLys is quite stable in basic conditions. It 
undergoes 11 % hydrolysis in 9 M potassium hydroxide at 100 ⁰C even after 9 hours. This is due to the 
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Scheme 1. Hydrolysis of pLys in physiological pH. 
 
1.3 pLys in biological systems 
So far, histone H1 is the only protein reported to contain pLys in vivo, isolated from regenerating 
rat liver nuclei. It was observed that histone H1 is more phosphorylated in a regenerating rat liver than 
in a normal rat liver.7 But its biological functions are still not clear. But a number of lysine kinase 
activities and pLys phosphatase have been reported. Smith reported a kinase that can phosphorylate 
Histone H1 in Walker-256 carcinosarcoma. They partially purified and studied the properties of kinase, 
which was found in the regenerating rat liver.8 Hiraishi discovered that inorganic pyrophosphatase from 
the bovine liver can dephosphorylate pLys and pHis. Additionally, LHPP and PHPT1, which are known 
as pHis phosphatases, are also reported to dephosphorylate chemically phosphorylated lysine.9 Still, 
pLys specific phosphatases are yet to be discovered.  
 
1.4 Current methods for studying pLys 
Previously, the putative Lys kinase activity was obtained from nuclear extracts and its kinase 
activity toward Histone H1 was observed. This was analyzed by 32P radiolabeling and paper 
chromatography to identify pLys.8,10 One of the major hurdles in the studies of pLys has the preparation 
of the pLys-containing peptides and proteins. Traditionally, chemical phosphorylation of Lys residues 
was performed with potassium phosphoramidate (PPA), as reported by Pia et al.9 Lysine residues of 
Histone H1 and polylysine was phosphorylated in vitro. Phosphorylation was analyzed by Malachite 
green phosphate assay, which analyze the amount of hydrolyzed phosphate group, and LC-MS/MS. 






 3  
In 2014, the Hackenberger group reported a synthetic method for site-specific pLys incorportation 
in peptides.11 They introduced an azidonorleucine in place of a Lys in a histone-derived peptide by SPPS, 
and through Staudinger phosphite reaction, the site-specific incorporation of a protected pLys was 
successfully achieved. They employed a phosphite with base- or UV- cleavable protecting group, and 
this phosphite were reacted with azide and finally deprotected with UV or base, providing the 
phospholysine peptide. The site-specific pLys incorporation was confirmed by electron-transfer 
dissociation (ETD) mass spectrometry. In fact, these pLys peptides were valuable in the studies of 
ionization and fragmentation behaviors of the pLys-peptides. But its preparation requires a long 
synthesis and its yields were low. And the protecting group should be deprotected right before use.11  
 
2. Development of pLys-specific antibody  
2.1 Design and strategy 
As described above, pLys was discovered in histones, but its detail biological functions are still 
unknown. One of the reasons for this lack of knowledge is that there were no essential and fundamental 
tools for studying pLys in proteins due to its chemical instability. Phosphorylation-specific antibodies 
have been among the most powerful tools for studying protein phosphorylation. If we can obtain pLys-
specific antibody, we can discover and isolate pLys-containing protein, and this can be extended to study 
pLys functions in biological systems. pLys is a phosphoramidate, which can be hydrolyzed easily. 
Therefore, it cannot be used as the hapten to generate pLys-specific antibodies. Instead, we designed a 
stable analog of pLys, which substituted the N-P bond with a more stable C-P bond (Figure 1). Similar 
synthetic hapten strategies have been successfully employed for the generation of pHis- and pArg-
specific antibodies. Our analog contains similar charge state of pLys at physiological pH, so we expected 
that this analog (pLys*) can mimic pLys.  
 
Figure 1. Structure of pLys and pLys analog. 
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2.2 Preparation of pLys-specific antibody 
2.2.1 Design and preparation of KLH-pLys analog (pLys*) immunogen 
The pLys* hapten, aminomethyl phosphonic acid, was conjugated to Keyhole Limpet Hemocyanin 
(KLH) by the glutaraldehyde-mediated conjugation followed by the imine reduction with sodium 
borohydride (Scheme 2). KLH is a well-known carrier protein for the generation of antibodies, due to 
its large size and abundant functional groups on the surface. The conjugation of pLys* hapten was 
confirmed by 31P NMR analysis. 
The pLys*-reactive antisera from rabbits were obtained by immunizing KLH-pLys* to two rabbits 
(performed at Young In Frontier). After each boost immunization, the test bleeds were checked by 
ELISA to monitor the titer to the pLys* hapten (BSA-pLys*). After five boosts, the rabbits were 
sacrificed, and the final bleeds were collected.  
Scheme 2. Conjugation of pLys* hapten to carrier protein KLH. 
 
2.2.2 Affinity purification of pLys*-specific antibodies 
To purify the pLys*-binding antibodies from the crude antisera, affinity purification was carried 
out. BSA-pLys* was coupled to the iodoalkyl moiety of Sulfolink-agarose® resin via its Cys residues. 
The crude antisera were affinity-purified using this BSA-pLys* agarose resin, but its specificity towards 
BSA-pLys* over other BSA-pX was still low. We hypothesized that the background binding antibodies 
may have bound to the glutaraldehyde linker between pLys* and the Lys sidechains of the antigen. So 
we performed the affinity depletion, which conjugates BSA-Linker without pLys* to the Sulfolink-
agarose resin to remove antibodies that binds to the non-specific part of antigen (Figure 2). After the 
two-step affinity purification, pLys*-specific antibodies were obtained.  
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Figure 2. Two-step purification of the pLys*-specific antibodies. 
 
 
2.3. Validation of the pLys-specific antibody 
2.3.1 ELISA studies 
The binding specificity of the purified antibodies toward pLys* was checked with ELISA. The 
binding of antibodies to BSA-pLys* and BSA-X (X = pSer, pThr, pTyr) were measured. We also used 
BSA and BSA-linker (no phosphoamino acid) to see the background non-specific binding.  
We confirmed that expected antibody was successfully obtained by immunization and two-step 
purifications described above. First, the affinity purification was performed with Sulfolink-BSA-pLys* 
resin. Although the desired antibody was mostly obtained in E1 and E2 fractions, other antibodies, which 
binds to the BSA-pX were not removed well, compared to the input fraction (Figure 3, upper panel). So 
we expected that these unwanted antibodies were binding to the linker of antigen, and synthesized a 
Sulfolink-BSA-Linker resin to performe the affinity depletion. After the affinity depletion, the desired 
antibody was observed in FT fraction with much better specificity. Other non-specific antibodies, which 
seems to bind to the glutaraldehyde linkers, were eluted in elution fractions (Figure 3, lower panel). 
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Figure 3. Two-step affinity purification of antisera and ELISA results. 
 
2.3.2 Dot blot and Western blot studies  
2.3.2.1 Poly-L-lysine and Histone H4 H18A H75A 
Poly-L-lysine was phosphorylated in vitro with potassium phosphoramidate (PPA) according to the 
literature.9 We tried western-blot analyses of the phosphorylated poly-L-lysine first, but due to abundant 
lysine groups, the bands were severely smeared on SDS-PAGE gels. Next, dot-blot analyses were 
performed for poly-L-lysine (Figure 4), but it showed strong non-specific binding to the non-
phosphorylated substrate. Therefore, we had to use different proteins substrates, but PPA-mediate 
phosphorylation can also phosphorylate His residues. So we switched to Histone H4 H18A H75A, in 
which all histidine residues were mutated into alanine, and we expected to see the phosphorylation of 
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phosphorylated poly-L-lysine and Histone H4 H18A H75A (Figure 5). 
 
Figure 4. Dot-blot analysis of phosphorylation of polylysine. 
 
Figure 5. Western-blot analysis of nonphosphorylated Histone H4 H18A H75A with anti-
pLys*. (Lane 1: Histone H4 H18A H75A Lane 2: BSA-pLys* (a positive control)) 
 
 
2.4 Conclusion and Future directions 
We designed the mimic of pLys and successfully obtained antibodies using the pLys analog as the 
hapten. Through two-step affinity purifications, pLys*-specific antibodies were purified. We tried to 
validate the antibody with pLys, but antibody bound to non-phosphorylated polylysine and Histone H4 
H18A H75A.  
Now, we are trying to find pLys-containing protein from mammalian cell lysates, such as 
HEK293T cell and HeLa cells through western-blots. We are also trying to do siRNA knockdown of 
pLys phosphatases to increase the chances to detect pLys containing proteins.  
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3. Experimental methods 
General materials 
(Aminomethyl)phosphonic acid and bovine serum albumin were purchased from Sigma Aldrich 
(St. Louis, MO). 1X TMB ELISA substrate was from eBioscience (San Diego, CA). Goat anti-rabbit 
IgG HRP conjugate was purchased from Biorad (Hercules, CA). Tris base salt was purchased from Alfa 
Aesar. SulfoLink® Coupling Resin was purchased from Thermo Scientific (Waltham, MA). 
 
General methods 
31P NMR spectra were recorded on a Bruker 400 AVANCE III HD (Bruker BioSpin, Billerica, MA). 
31P NMR chemical shifts are reported in parts per million (ppm). Absorbance in microplate was 
measured with SpectraMax i3x (Molecular devices, Sunnyvlae, CA). Protein concentration was 
measured at 280 nm by NanoDrop™ 2000/2000c (Thermo Scientific, Waltham, MA). 
Chemiluminescence from western blot and dot-blot analysis was measured with ChemiDoc™ XRS+ 
System (Biorad, Hercules, CA). 
 
General protocol of BSA-pX conjugation  
To a 2 mL of BSA solution (4 mg/mL), 10 mg of a phosphoamino acid was added in a conical tube. 
1 mL of glutaraldehyde solution (20 mM in PBS) was added dropwise. Upon addition, the reaction 
mixture started turning yellowish, and it was incubated until the yellow color fully developed. Then, 
250 μL of NaBH4 solution (10 mg in 1 mL of PBS) was added dropwise. The mixture was incubated at 
room temperature until the bubbling subdued, by which time the mixture was colorless. The conjugate 
was dialyzed twice in 450 mL of PBS buffer with 3500 MWCO SnakeSkin®  Dialysis Tubing for 8 
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31P NMR data of BSA-pLys* conjugation  
 
Figure 6. 31P NMR of BSA-pLys* after dialysis 
 
31P NMR (162 MHz, D2O)   (BSA-pLys*),   (PBS buffer) 
 
Preparation of Sulfolink-agarose-BSA-pLys* and BSA-Linker 
Overall procedures were according to the manufacturer’s instruction. DTT (2 mg) was added into 
2 mL of BSA-pLys* or BSA-Linker solution. Dialysis was followed, twice in 300 to 400 mL of resin 
coupling buffer (50 mM Tris, 5 mM EDTA-Na, pH 8.5) for 4 hr each. SulfoLink® Coupling Resin (1 
mL) was loaded to a biospin column after stirring for suspension. Then, the column was washed with 
the resin coupling buffer (1 mL, each, more than 5 times) and drained. The BSA-linker or BSA-pLys* 
solution (1 mL) was loaded into the resin column and incubated on a rocker for 30 min, then column 
was kept standing up for additional 30 min at RT without mixing. The remaining protein concentrations 
were monitored by absorbance at 280 nm with Nanodrop®. After the coupling, the remaining reactive 
sites of resin were blocked by incubation with the quenching buffer (1 mL, 50 mM L-cysteine 
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hydrochloride in the coupling buffer) for 15 min with mixing, and reaction was incubated by standing 
the column upright without mixing for additional 30 min. To remove the quenching buffer, column was 
drained and washed with the wash solution (1 M NaCl, 5 x 1 mL). The column was finally washed with 
the storage buffer (PBS) and stored store at 4 C upright.  
 
Preparation of the antisera 
Production of polyclonal rabbit antisera of KLH-pLys* was requested to Young In Frontier (Seoul, 
Republic of Korea). Two New Zealand White Rabbit were immunized 5 times with the requested antigen. 
After each boost immunization, the titer of the crude antisera towards BSA-pLys* was checked with 
ELISA. After the 5th boost, the final bleed was obtained to provide the crude antisera.  
 
Affinity purification and depletion 
For the affinity purification, a BSA-pLys* conjugated agarose resin was used, and a BSA-Linker 
conjugated agarose resin was used for affinity depletion. The conjugated agarose resin was washed with 
1 mL of the wash buffer (TBS, 25 mM Tris, 137 mM NaCl, 2.7 mM KCl, pH 8.5) for 5 times. The 
crude antiserum (100 μL) was diluted with 900 μL of TBS-Tween (0.1 % Tween in TBS) and loaded 
on the BSA-pLys* column. After gentle mixing, the column was incubated on a rocker for 1 hour at 
room temperature. The flow-through was collected and column was washed with 1 mL of TBS for 5 
times. Each wash fraction (total 5 fractions) was collected separately. The antibodies were eluted with 
900 µL of the elution buffer (0.1 M Glycine, pH 2.5). Each eluted fraction was neutralized immediately 
to pH 7 with 50~100 μL of the neutralization buffer (1 M Tris, pH 8.6). The flow-through, wash 
fractions, and elution fractions were diluted into 1:50 for affinity purification and 1:20 into TBS-Tween 
for depletion, and they were analyzed by ELISA.  
 
General procedure of ELISA 
BSA-conjugated pX was dissolved in the ELISA coating buffer (0.1 M Sodium carbonate, pH 9.6) 
and diluted into 50 μg/µL. An immunoplate (SPL, Cat. No.: 32296) was coated with 50 μL of each BSA-
conjugated pX solution for 1 or 2 hours on a rocker at RT. The wells were washed with TBS-T (TBS pH 
8.5, 0.1 % Tween 20) 3 times, followed by blocking with the blocking buffer (3 % BSA in TBS-T) for 
1 hour on a rocker at RT. After the removal of the blocking solution, the crude or purified antisera were 
diluted into 1:2000 in TBS-T. The diluted antisera solution (50 µL) was added to the wells and incubated 
on a rocker at least for 1.5 hr at RT. The wells were washed 3 times with TBS-T. Goat anti-rabbit IgG 
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HRP conjugate (Biorad, Cat.No.: 1706515) was diluted 1:5000 in TBS-T, and 50 µL of this secondary 
antibody solution was added to each well and incubated for 30 min at RT on a rocker. After washing 
with the washing buffer 3 times, 50 µL of 1X TMB ELISA substrate (eBioscience, Cat. No.: 00-4201-
56) was added to each well, and it was incubated on rocker for 10 min, by which time blue green color 
developed. Then, 50 µL of 2 N sulfuric acid was added to stop the reaction, and the wells immediately 
turned yellow. The optical density was measured at 450 nm by a plate reader. 
 
General procedure of Western blots 
Western blots were performed according to the following procedures. Samples were loaded on a 
12 % SDS-acrylamide gel with 4 X loading buffer (pH 8.5). After running the electrophoresis, transfer 
was performed to an Immun-Blot PVDF Membrane (Biorad, Cat.No.: #162-0177), at 100 V for 1.5 hr 
at  C. After the transfer, the membrane was blocked with 3% BSA in TBS-T for 1 hr. Subsequently, 
the membrane was incubated with 1 antibody (purified pLys*-specific antiserum, diluted 1:2000 
diluted into TBS-T) for 1.5 hr at RT. The membrane was washed 3 times with TBS-T. After incubation 
with the secondary antibody (goat anti-rabbit IgG HRP conjugate) for 30 min at RT, the membrane was 
washed 3 times with TBS-T 3 times. Finally, the membrane was incubated with ECL chemiluminescence 
substrate, D-Plus™ ECL Pico System, (Dongin LS, Cat.No.: ECL-PS100) for 5 min and the 
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Chapter 2. Chemical biology tool for study Bacterial TCS 
 
1. Introduction 
1.1 Bacterial TCS 
 
Figure 7. Mechanistic diagram for bacterial TCS (a) and phosphorelay (b) systems. 
(adopted from Reference 1, Copyright reserved) 
 
Two-component systems (TCSs) are key sensory systems found in bacteria and plants. They sense 
a variety of external physical and chemical stimuli, such as temperature, pH, antibiotics, and regulate 
the cellular responses accordingly. 1 , 2  In the TCS, phosphorylation of unconventional amino acid 
residues, such as histidine (His) and aspartic acid (Asp) are crucial for the signaling cascade. The 
histidine kinase (HK), which is embedded in the cell membrane, is the sensor of TCS. Most HKs are 
homodimeric proteins consisting of the N-terminal sensing domain and the C-terminal cytoplasmic 
kinase domain. If extracellular stimuli activate the sensing domain of a HK, the HK autophosphorylates 
its specific His residue on the dimerization domain (DHp domain). Then, its cognate response regulator 
(RR) catalyzes the transfer of the phosphoryl group from phosphohistidine (pHis) of the HK to a specific 
Asp residue in its regulatory domain. This phosphorylation on regulatory domain activates the effector 
domain of the RR. The activated RR can act as transcriptional factor, regulating the target gene 
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expression and the resulting physiological responses to the stimuli.1 A phosphorelay system, a more 
complex variation of TCS, consists of multiple transphosphorylation steps. A hybrid histidine kinase 
autophosphorylates its His site and the phosphoryl group is intramolecularly transferred to an Asp 
residue. Then, the histidine-containing phosphotransfer (HPt) protein transfers this phosphoryl group 
of pAsp to its own His and eventually to an Asp residue of the cognate RR (Figure 7).   
Some HKs also have RR phosphatase activity. Not only HKs, but some RRs also contains 
autophosphatase activity, and these phosphatase activities shorten the lifetime of pAsp in vivo and make 
studies of pAsp more difficult. 
 
1.2 Biological functions and significance of TCS  
In bacteria, TCSs regulate various physiological responses to external physical and chemical stimuli. 
TCSs are involved in important phenomena such as chemotaxis, biofilm formation, and antibiotic 
resistance. In plants, TCSs regulate the perception and signaling of cytokinin and ethylene signaling.3 
To date, over 80,000 TCSs have been found in various prokaryotes.4 However, for the vast 
majority, the cognate signal for the individual TCS is not known. Even for the cases where their cognate 
input signals are known, the detailed sensing mechanisms are still unclear. So far, in E.coli, about 30 
TCS have been discovered, but their functions are only partially revealed. Only some external signals 
and its correlated TCS have been discovered since 1987.5  
In general, a HK and its target RR has a one-to-one relationship, but some TCSs are known to have 
cross-talks between multiple HKs and RRs. With classical methods such as knockdown studies, 
however, it is difficult to analyze the complicated network between TCSs.  
Characterization of the signal-TCS relationship can promote our understanding of bacterial 
signaling systems, which is fundamentally important for basic microbiology. Additionally, its 
application to the development of biosensors based on the bacteria will have tremendous practical 
significance. For example, if new TCSs that recognize heavy metals or toxins are elucidated, these can 
be potentially used as cell-based biosensors and bioswitches.  
 
1.3 Chemistry of pAsp 
 Among phosphoamino acids, pAsp is probably the most difficult one to study since it is an acyl 
phosphate, which is unstable both in acidic and basic conditions as well as in neutral pH if certain 
nucleophiles are present. It is thermodynamically and kinetically unstable. According to the literature, 
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standard hydrolysis free energy of acetyl phosphate, a model acyl phosphate, is -10.3 kcal/mol. 
Compare to the hydrolysis energy of ATP to ADP, which is -7.3 kcal/mol, acetyl phosphate is 
thermodynamically more poised towards hydrolysis.6 This can be explained with two reasons. First, 
due to the delocalization of lone pair on the bridging oxygen to the phosphorus (Scheme 3, right 
structure). Resonance form of acyl phosphate implies a positive charge on bridging oxygen. Therefore, 
these resonance structures cannot contribute to stabilize acyl phosphate. The second reason is that the 
hydrolysis products of pAsp can be more readily ionized and more strongly solvated than the starting 
material, leading to large free energy of hydrolysis of acyl phosphate.7 Kinetic stability of pAsp was 
measured and reported. At 30 ˚C, pH 4 to 10, 30 % hydrolysis of pAsp was observed within 30 min.8 
 
 
Scheme 3. Resonance structures of acyl phosphates. 
 
1.4 Current detection methods for pAsp 
Several papers describe the detection methods for pAsp in proteins. A classical method is the 
radioactive labeling using [-32P] ATP to measure the radioactivity of the phosphorylated target protein.9 
This is a very sensitive method for detection of phosphoamino acids in protein. But it expensive and 
dangerous since it uses radioactive material.  
Another method is to convert pAsp into homoserine (Hse). pAsp can be selectively reduced and 
transformed into Hse with NaBH4 (Scheme 4). Sometimes tritium-labeled NaB3H4 was used to detect 
the labeled Hse by radioactivity. This reduction method is frequently used to confirm the pAsp site in 
protein, combined with tandem mass spectrometry.10,11 
 
 
Scheme 4. Conversion of pAsp residue into Hse by NaBH4. 
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2. Covalent-labeling of pAsp in proteins 
 As described above, it would be extremely useful to identify which specific TCSs are activated 
under certain external stimuli. To observe it, it is essential to analyze and quantify the pAsp-containing 
RRs in the proteomes. But since pAsp is easily hydrolyzed, it is difficult to analyze the pAsp-containing 
proteins in classical phosphoproteomics which require acidic condition in elution of phosphopeptide. 
Therefore, we aim to develop new methods to specifically label pAsp residues in proteins. In the 
following sections, our progress in this labeling strategy using in vitro model systems is described. We 
expect that this methodology will also be very useful to investigate other pAsp-containing proteins than 
the study of TCS.  
 
2.1 Strategy and work flow of pAsp labeling in RR  
 
Figure 8. Scheme of hydroxamate based covalent pAsp labeling. 
 Our project aims to analyze TCS through development of specific covalent labeling methods for 
pAsp in proteins (particularly activated RR). This way, it would be possible to identify which specific 
TCSs are activated under certain stimuli. Hydroxylamine is used as nucleophile for pAsp. Since acyl 
phosphate reacts with hydroxylamine in aqueous solution, pAsp will be labeled into the Asp-
hydroxamate (Figure 8). Our design is based on the fact that other amino acids in proteins have low 
reactivity toward nucleophiles, and this labeling method is expected to be specific to pAsp. Then, we 
also plan to develop methods that can selectively purify the hydroxamate-labeled pAsp. Through this 
methodology, combined with proteomic analyses through tandem mass spectrometry, we will be able 
to detect various TCS activation at the same time in response to certain stimuli. In addition, this 
methodology does not require any genetic manipulation, as in reporter gene assays. 
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2.2 Nucleophiles for acyl phosphate 
Previously, Wenjie Ma in our research group tested various nucleophiles on acyl phosphate, using 
benzoyl phosphate as a pAsp model. Several water-soluble nucleophiles were tested. −Nucleophiles 
have high nucleophilicity due to the delocalization of lone pair electrons of the adjacent heteroatom to 
the nucleophilic center.12 A series of −nucleophile including hydroxylamine, hydrazine and their 
derivatives, such as oxime, hydrazone and hydroxamic acids were synthesized and tested in pH 7, Tris 
buffer (Scheme 5). Reactions were monitored by HPLC and based on the data, reaction rate was 
calculated. The result showed that hydrazine and hydroxylamine were most reactive, and they exhibited 
enhanced reactivity in presence of magnesium ion. Several substituted derivatives of hydroxylamine or 
hydrazine were also tested, but still hydroxylamine showed best reactivity toward benzoyl phosphate.13 
 
Scheme 5. Test of -nucleophiles to benzoyl phosphate. 
When hydroxylamine reacts with an acyl phosphate, it forms a hydroxamate. It is known that 
hydroxamates have high affinity toward various metals and metal oxides, such as Fe3+ and TiO2. If pAsp 
residues in proteins and peptides can be covalently labeled as the hydroxamate, we expect that using 
immobilized metal affinity chromatography (IMAC), selective enrichment of hydroxamate-labeled 
proteins and peptides will be possible.  
 
2.3 In-vitro covalent labeling of RR  
2.3.1 Phosphorylation of RR 
2.3.1.1 Phosphorylation by small molecules 
It is known that some bacterial response regulators (CheY, OmpR, PhoB, etc.) can be 
phosphorylated at specific Asp residues in vitro by small-molecule phospho-donors, such as acetyl 
phosphate, phosphoramidate, and carbamoyl phosphate. In the case of CheY, all three phospho-donors 
successfully phosphorylated it. 14 , 15  This small-molecule phosphorylation was identified with 
radiolabeled acetyl [32P] phosphate, in the presence of magnesium ion. CheY phosphorylation was also 
monitored by its intrinsic tryptophan fluorescence change after phosphorylation since it has only one 
Trp residue and its fluorescence was quenched by the nearby pAsp.  
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 To repeat this phosphorylation in our hands, recombinant CheY was expressed and purified. 
Firstly, phosphorylation with acetyl phosphate was performed with 4 M of CheY in 0.1 M Tris pH 7.0 
with 8.8 mM of MgCl2. To our delight, after addition of acetyl phosphate, decrease of the Trp 
fluorescence (295 nm excitation and 360 nm emission) was observed. Decrease of the fluorescence after 
the phosphorylation was around 40 % in 20 to 40 mM acetyl phosphate, which is consistent with the 
literature (Figure 9).16 CheY phosphorylation was also analyzed by MALDI-TOF MS and ESI-MS. 
Both analyses showed an +80 Da increase in the CheY protein mass after phosphorylation (Figure 10).  
 
 
Figure 9. CheY fluorescence quenching by the phosphorylation with AcP.   
(I0: Initial fluorescence intensity (before phosphorylation), I: Fluorescence intensity after 
phosphorylation, △I= I-I0) 
 
To this Asp-phosphorylated CheY, covalent labeling with hydroxylamine was attempted. Indeed, 
the fluorescence recovery was observed when 1 M hydroxylamine was added to the phosphorylation 
reaction mixture, suggesting that pAsp was converted to a different product, either a hydroxamate or an 
Asp (Figure 11). Unfortunately, the +15 Da difference between the nonlabeled Asp and the hydroxamate 
product was difficult to be distinguished with ESI-MS or MALDI-TOF MS. Therefore, we analyzed 
the hydroxylamine-treated CheY by LC-MS/MS, but the +15 Da increase on desired Asp residue was 
not observed. We attribute this lack of labeling to the competing reaction between the remaining acetyl 
phosphate and hydroxylamine, but the exact reason is still unclear. So we decided to carry out the 
phosphorylation without acetyl phosphate, via transphosphorylation of the RR by its cognate HK. 
 




Figure 10. ESI-MS result of (a) CheY and (b) pCheY (positive mode). 
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Figure 11. Fluorescence recovery after HA addition. 
 
 
2.3.1.2 Transphosphorylation of a RR by its cognate HK 
In a TCS, if a signal from outside activates the sensor HK, the HK phosphorylates its own His 
residue. The phosphoryl group from the pHis is then transferred to a specific aspartate residue of the 
cognate RR. Ishihama group characterized the trans-phosphorylation of RRs by HKs with various 
combinations of TCS system from E.coli.17 They expressed and purified 30 HKs and 34 RRs including 
putative HK/RR candidates. Their phosphorylation was monitored by in vitro radiolabeling assays with 
[-32P] ATP. The levels of the autophosphorylation of the HKs and the trans-phosphorylation the RRs 
were analyzed by measurement of the intensity of 32P radioactivity. 
Encouraged by this precedence, we tested the transphosphorylation of GlrK-GlrR and EnvZ-
OmpR HK-RR pairs. His6-tagged HKs and RRs were recombinantly expressed and purified. After 
purification, the autophosphorylation of the HK and the subsequent trans-phosphorylation to the RR 
was performed using non-radioactive ATP as the substrate. 
Generally, an RR act as a transcriptional factor, regulating the target gene expression. But in the 
case of CheY, a chemotaxis protein of E.coli, it binds and regulates the activity of its target protein FliM. 
Attractants and repellents bind to the cell surface domain of protein CheA, a receptor histidine kinase, 
and CheA phosphorylates CheY. When phosphorylated, CheY binds to the N-terminal segment of FliM 
via conformational change. FliM constitutes the switch complex of the flagellar motor and involved in 
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clockwise rotation.18 
 OmpR is involved in the regulation of osmolarity of E.coli by modulate porins. OmpR act as a 
transcriptional factor of OmpF and OmpC, which are outer membrane proteins that form pores to allow 
the diffusion of small molecules. The level of phosphorylation of OmpR is determined by its cognate 
HK, EnvZ. In high osmolarity growth media, the phosphorylation level of OmpR was increased.19 
 
2.3.2 Covalent labeling of phosphorylated RRs 
After the trans-phosphorylation, hydroxylamine hydrochloride solution (pH 7) was added to a final 
concentration of 2 M. The reaction was performed at RT for 1 h, followed by desalting with reversed-
phase R2 poros resin to remove excess hydroxylamine before the protein digestion. Subsequently, the 
protein digestion was performed with trypsin. Since OmpR has long tryptic peptides around the known 
pAsp sites, a double-digestion was carried out with Glu-C endoproteinase. 
 
2.3.3 LC-MS/MS analysis  
Two hydroxylamine (HA)-treated samples were prepared, both with phosphorylated OmpR 
(pOmpR-HA) and non-phosphorylated RR(OmpR-HA). After the double digestion using trypsin and 
Glu-C, LC-MS/MS analysis was performed by Prof. Jeong-Kon Seo at UCRF, UNIST. The target 
peptides harboring the known pAsp site (D55) were observed in both samples, but not all amino acids 
in the target peptide were read in LC-MS/MS. To our delight, the amino acids around the known pAsp 
site (D55) was read and 15 Da increase was observed in pOmpR-HA, supporting that it had been 
converted to a hydroxamate, presumably via pAsp (). Additionally, no hydroxamate (D+15 Da) was 
observed in the corresponding site in OmpR-HA.  
Following the same procedure, pGlrR-HA and GlrR-HA were prepared and analyzed by LC-
MS/MS. Consistent with the result of pOmpR-HA and OmpR-HA, only phosphorylated GlrR showed 
the +15 Da modification on Asp on D66 (Figure 13). So, our covalent labeling approach was validated 
in two TCS systems in vitro.  
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Figure 12. LC-MS/MS analysis of OmpR-HA and pOmpR-HA. The presence of pAsp in 
Asp55 (b8 and b9) was observed. 
 
Figure 13. LC-MS/MS analysis of GlrR-HA and pGlrR-HA. The presence of pAsp in Asp56 
(y2 and y3) was observed. 
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2.4 Conclusion and future directions 
We demonstrated that the covalent in vitro labeling of pAsp in RR proteins with hydroxylamine 
after enzymatic phosphorylation and transphosphorylation in two TCS pairs, EnvZ-OmpR and GlrK-
GlrR. The LC-MS analysis clearly indicated the successful phosphorylation of CheY, but the subsequent 
covalent labeling was not observed in this case. Now we are focusing on the reproducibility of our 
labeling esperiments and the subsequent enrichment of the hydroxamate-labeled peptide with IMAC 
approaches. 
During the preparation of this thesis, a quite similar covalent labeling strategy for pAsp in RRs 
using an alkoxyamine nucleophile was reported.20 However, in our own studies, such nucleophiles 
showed very low reactivity to acyl phosphates. So it should be tested if such strategies can be applied 
to the detection of low-level pAsp in RRs. Head-to-head comparison of our hydroxylamine-based 
method and their method should be helpful.   
 
3. Experimental method 
 
General materials 
Trypsin and Glu-C were purchased from Thermo Scientific (Pittsburgh, PA). All biological reagents 
(unless other noted) were purchased from Bio-Rad (Hercules, CA). Adenosine 5’-diphosphate sodium 
salt (ATP) and lithium potassium acetyl phosphate were purchased from Sigma-Aldrich (St. Louis, MO), 
and magnesium chloride*hexahydrate (MgCl2) was purchased from Biosesang (Seongnam, Republic of 
Korea). Tris base salt was purchased from Alfa Aesar. All other salts in buffer solution and 
hydroxylamine hydrochloride were purchased from Daejung (Siheung, Republic of Korea). All reagents 
used in LC-MS/MS analysis were provided by Prof. Jeong-Kon Seo.  
 
General methods 
Mass spectra were measured with Q ExactiveTM Plus Hybrid Quadrupole-OrbitrapTM mass 
spectrometer (Thermo Scientific, Waltham, MA), by Prof. Jeong-Kon Seo at UCRF, or with Ultraflex 
III-MALDI-TOF/TOF (Bruker BioSpin, Billerica, MA). Fluorescence was measured with SpectraMax 
i3x (Molecular devices, Sunnyvale, CA). Fluorescence of CheY protein was measured at excitation 
wavelength 295 nm and emission wavelength at 360 nm. PCR was performed with T100™ Thermal 
Cycler (Thermo Scientific, Waltham, MA). DNA or protein concentration was measured by 
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NanoDrop™ 2000/2000c (Thermo Scientific, Waltham, MA). 
 
Plasmid construction for recombinant protein  
 Plasmid containing the HK catalytic domain and the full-length RR were prepared by PCR-based 
restriction-free cloning method.21 E.coli genomic DNA was used as the template and primers were 
designed with an online tool (http://rf-cloning.org). Primers were synthesized at Macrogen (Seoul, 
Republic of Korea). PCR-amplified megaprimer was incorporated into a pET21a(+) vector (with a C-
term His6-tag) by overlap-extension PCR. For overlap-extension PCRs, Phusion High-Fidelity PCR 
Master Mix with HF Buffer (Thermo Scientific, Catalog No.: F531S) was used. MAX Efficiency® 
DH5αTM Chemically Competent Cells (Invitrogen, Catalog No.: 18258-012) was used as the host for 
transformation. All plasmid sequences were confirmed by DNA sequencing (Macrogen, Korea).  
 
Preparation of the megaprimers for overlap-extension PCR 
PCRs were performed according to the literature.21 Primers (Table 1) were diluted into 100 μM 
with distilled water. For megaprimer synthesis, 10 μL of 2 X Phusion High-Fidelity PCR Master Mix 
was added and 2 μL of forward and reverse primer respectively. Then, 1 μL of E.coli genomic DNA 
was added (50 ng/μL). Distilled water was added, and final volume of sample was 20 μL. In case of 
cloning of HK, 0.8 μL of DMSO was added additionally. PCRs were run using the following parameters 
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Primers 
 
Table 1. Forward and reverse primers used in PCR. 
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Step Temperature Time 
Initial denaturation 98 °C 10 sec 
Cycles 
(25~30 repeats) 
Denaturation 98 °C 1 sec 
Annealing 55 °C to 65 °C 5 sec 
Extension 72 °C 15 sec 
Final extension 72 °C 2 min 
Table 2. PCR method for megaprimer synthesis. 
Finally, the megaprimer was purified by 0.8 % agarose gel electrophoresis and AccuPrep® Gel 
Purification Kit (Bioneer, K-3035). The product megaprimer concentration was measured by Nanodrop®. 
 
Overlap-extension PCR  
To a 10 µL of 2 X Phusion High-Fidelity PCR Master Mix, 20~40 ng of vector and 100 ng of 
megaprimer was added. Final volume was adjusted into 20 µL with distilled water. Overlap-extension 
PCRs were run using the following parameters (Table 3).21 
 
Step Temperature Time 
Initial denaturation 96 °C 30 sec 
Cycles 
(25~30 repeats) 
Denaturation 96 °C 30 sec 
Annealing 55 °C to 65 °C 60 sec 
Extension 72 °C 2-3 min 
Final extension 72 °C 7 min 
Table 3. Method of overlap-extension PCR. 
 
Final product was treated with FastDigest DpnI (Thermo Scientific, Cat. No.: FD1703) for 5 min 
at 37 °C according to the manufacturer’s instruction to remove the original vector template.  
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Transformation and mini-prep 
The transformation was performed according to the NEB website protocol. To a 50 μL stock of 
Maxeffciency DH5TM chemically competent cells (Invitrogen, Cat. No: 1701602)  μL of the desired 
plasmid was carefully added without vortexing. After incubation on ice for 30 min, heat shock was 
performed for 45 sec at 42 °C, and the cells were immediate kept on ice for at least 2 min for membrane 
recovery. To this, 450 μL of LB broth without antibiotics was added and the mixture was incubated on 
a shaker for 3 hr at 200 rpm. Then, the transformed cell stock (50 to 100 μL) was spread on an agar plate 
containing the desired antibiotic and incubated overnight at 37 °C. On the next day, colonies were picked, 
and each colony was inoculated in a 5 mL of LB broth which contains ampicillin and incubated on a 
shaker for 8 to 16 hr at 37°C, 200 rpm.  
 
Mini-prep was done with AccuPrep® Nano-Plus Plasmid Mini Extraction Kit (Bioneer, Cat. No.: 
K-3111), according to the manufacturer’s instruction. The purified plasmids were quantified with 
Nanodrop® and sequencing was performed at Macrogen (Seoul, Republic of Korea). Sequencing result 
was confirmed by BLAST website (https://blast.ncbi.nlm.nih.gov/Blast.cgi).  
 
Expression and purification of recombinant proteins 
 Expression and purification of recombinant E. coli proteins were carried out following the 
literature.22 BL21(DE3) pLysS Competent Cells (Promega, Catalog No.: L1191) was used as host, HK- 
His6 (cytoplasmic domain) and RR-His6 (pET21a(+) derivative containing RR and HK from E.coli) was 
used as plasmid. To a 200 mL of LB broth with the antibiotic, 2 mL of the transformed cell stock was 
inoculated and cultured on a shaker at 37 °C, 200 rpm. At OD600 of 0.6~0.7, IPTG stock solution (final 
1 mM) was added for induction. After incubation at 37 °C for 3 h, cells were harvested by centrifugation 
at 4 °C, 4000 rpm for 30 min.  
 
Cell lysis 
After centrifugation, cell pellet was resuspended in B-PER™ Complete Bacterial Protein 
Extraction Reagent (Thermo Scientific, Catalog No.: 89822) with 2 mM PMSF. 1 mM EDTA was added 
in case of BL21(DE3) competent cell lysis. For a 200 mL culture, 4 mL of B-PER Complete buffer was 
used. All lysis procedures were carried out with standard protocol according to the manufacturer’s 
instruction. The lysate was centrifuged at 4000 rpm for 30 min at 4 °C and the supernatant was purified 
by Ni-NTA affinity purification. 
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Ni-NTA protein affinity purification 
 From the cell lysate, the His6-tagged protein was purified by HisPur™ Ni-NTA Resin (Thermo 
Scientific, Catalog No.:88223). Ni-NTA was performed according to the standard protocol from 
manufacturer’s instruction. To a 3 mL of Ni-NTA resin slurry, 4 to 5 mL of the lysate was added. Lysate 
was incubated 30 min at RT on a rocker. After incubation, purification was performed. All buffers were 
prepared with 50 mM Tris-HCl, pH 7.5, and 20 mM imidazole was added to the equilibrium and wash 
buffers. The elution buffer contained 100 mM or 200 mM of imidazole. Each fraction contains 3 mL of 
washed or eluted sample. 5 wash fractions and 6 elution fractions were analyzed by SDS-PAGE and its 
concentration was measured by Bradford assay after dialysis and concentration of protein. Total 9 mL 
of clean elution fractions were combined and dialyzed three times (for 2 to 4 h each time) at 4 °C in 1 
L of 50 mM Tris-HCl, pH 7.5.  
 
Autophosphorylation of HK and transphosphorylation to RR  
The recombinant HK was diluted in TBS pH 7.8, into final concentration of 5 μM. 
Autophosphorylation was performed by addition of ATP and MgCl2, both at final concentration of 5 
mM. Autophosphorylation reaction was carried out for 1~2 hr at 37 °C. Then, equimolar amount of RR 





Figure 14. SDS-PAGE of the purified proteins, stained by Coomassie blue. From left, (1) 
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In-solution digestion 
After desalting of reaction samples, elution fraction was dried by speed-vac. Then, proteins were 
denatured by addition of 8 M urea. After denaturation, disulfides were reduced with DTT (final 15 mM) 
at 56 °C for 1 hr and subsequently alkylated by treatment of iodoacetamide (final 55 mM) at 25 °C for 
30 minutes. The digestion was done in a total volume of 250 µL, adjusted with 50 mM ammonium 
bicarbonate, pH 8. Trypsin was added to 1:50 protease to protein mass ratio. After 2 hr digestion at 
37 °C, same amount of Glu-C was added, and reaction was kept overnight (13 h) at 37 °C. After the 
digestion, desalting was done by R2 reversed-phase chromatographic resin. Peptide fragments were 
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